Membranes were then blocked with 5% nonfat milk in Tris-buffered saline with Tween 20 (TBST) for 1 h and probed with primary antibody at 4C overnight

On By msisig

Membranes were then blocked with 5% nonfat milk in Tris-buffered saline with Tween 20 (TBST) for 1 h and probed with primary antibody at 4C overnight. Sf-Stk, resulting in the inability of these proteins to promote the Epo-independent growth of erythroid progenitor cells. We also demonstrate that the interaction of gp55 with Sf-Stk does not promote dimerization of Sf-Stk but results in enhanced phosphorylation of Sf-Stk and the relocalization of Sf-Stk from the cytosol to Ursolic acid (Malol) the plasma membrane. Finally, we demonstrate that a constitutively active form of Sf-Stk (Sf-StkM330T), as well as its human counterpart, Sf-Ron, promotes Epo-independent colony formation in the Ursolic acid (Malol) absence of gp55 and that this response is also dependent on the cysteines in the extracellular domains of Sf-StkM330T and Sf-Ron. These data suggest that the cysteines in the extracellular domains of Sf-Stk and Sf-Ron may also mediate the interaction of these truncated receptors with other cellular factors that regulate their ability to promote cytokine-independent growth. Since Friend disease was first reported in 1957 (19), the acute erythroleukemia induced by the various strains of Friend virus have provided an excellent model to study multistage carcinogenesis (5). In the first stage, the virus infects erythroid Ursolic acid (Malol) progenitor cells and a viral glycoprotein, gp55, interacts with both the erythropoietin receptor (EpoR) and a naturally occurring truncated form of the stem cell-derived tyrosine kinase (Stk), Sf-Stk, resulting in the Epo-independent (Epoind) expansion of erythroid progenitor cells. The late stage of erythroleukemia in Friend disease is marked by inactivation of thep53locus (6,28,38,39,51) and proviral integration into theSpi-1locus (36,43,44), resulting in enhanced expression of Ursolic acid (Malol) Pu.1, which causes a block in erythroid differentiation and promoting the onset of acute erythroleukemia. Friend virus is a complex of two viruses, the spleen focus-forming virus (SFFV), which is a Mouse monoclonal to SKP2 replication-defective C-type retrovirus, and the ecotropic Friend murine leukemia virus (F-MuLV). SFFV is responsible for the rapid splenomegaly and acute erythroleukemia induced by Friend virus infection (7,64,65,67), while F-MuLV provides helper function and can be substituted for by other murine leukemia viruses (35). Specifically, the glycoprotein gp55, encoded by the SFFVenvgene, acts as the transforming viral oncoprotein (2,65). Several loci in the mouse genome that control Friend virus susceptibility have been identified.Fv1,Fv3, andFv4affect the ability of Friend virus to infect early erythroid progenitor cells. TheFv1gene product inhibits Friend virus infection by interacting with the viral capsid protein (60). TheFv3gene encodes cytidine deaminase Apobec3, which broadly inhibits retrovirus infection (42,53,57). TheFv4gene product affects viral binding by competing for receptors on the cell membrane (59). Another set of genes,W,Sl,f, andFv2, are required for the development or expansion of infected progenitor cells. Our previous work demonstrated thatW,Sl, andf, which encode the kit receptor, its ligand SCF, and Smad5, respectively, also play key roles in the BMP4-dependent stress erythropoiesis pathway(46,47,55). Analysis of those mutants showed that Friend virus activates this pathway, leading to acute amplification of stress progenitors, which are targets of Friend virus in the spleen, and resulting in rapid onset of disease. The Friend virus susceptibility geneFv2encodes the stem cell-derived tyrosine kinase (Stk) receptor (48). A naturally occurring N-terminally truncated form of Stk, short-form Stk (Sf-Stk), is required for Friend virus susceptibility.Fv2r/rmice, including C57BL/6, lack expression of Sf-Stk and are resistant to Friend virus infection, while full-length Stk expression is unaffected in these mice. An internal promoter within the Stk locus drives Sf-Stk expression, andFv2r/rmice harbor mutations in the internal promoter. Sf-Stk lacks the N-terminal ligand binding domain of full-length Stk but retains the transmembrane and tyrosine kinase domains.In vitroandin vivoexpression of Sf-Stk in C57BL/6 bone marrow cells has been shown to confer Friend virus susceptibility toFv2r/rmice (18). Sf-Stk covalently interacts with gp55, resulting in constitutive activation of Sf-Stk (41). However, the mechanism by which this occurs is currently unknown. Here, we identify cysteines in the extracellular domains of Sf-Stk and gp55 that mediate this interaction. Furthermore, we demonstrate that while the association with gp55 is not required for the dimerization of Sf-Stk, the interaction of gp55 with Sf-Stk promotes tyrosine phosphorylation of Sf-Stk. In addition, while the extracellular cysteines in Sf-Stk promote retention of Sf-Stk in the cytoplasm in the absence of gp55, the interaction of Sf-Stk with gp55 through these cysteines results in enhanced cell surface localization of Sf-Stk. These changes in receptor activation and subcellular localization mediate the ability of Sf-Stk to induce gene expression and promote the Epoindgrowth of primary erythroblasts. == MATERIALS AND METHODS == == Antibodies and cell culture reagents. == HEK 293 cells and CHO cells were maintained in.